Your browser doesn't support javascript.
loading
Targeting ferroptosis: A novel therapeutic strategy for the treatment of mitochondrial disease-related epilepsy.
Kahn-Kirby, Amanda H; Amagata, Akiko; Maeder, Celine I; Mei, Janet J; Sideris, Steve; Kosaka, Yuko; Hinman, Andrew; Malone, Stephanie A; Bruegger, Joel J; Wang, Leslie; Kim, Virna; Shrader, William D; Hoff, Kevin G; Latham, Joey C; Ashley, Euan A; Wheeler, Matthew T; Bertini, Enrico; Carrozzo, Rosalba; Martinelli, Diego; Dionisi-Vici, Carlo; Chapman, Kimberly A; Enns, Gregory M; Gahl, William; Wolfe, Lynne; Saneto, Russell P; Johnson, Simon C; Trimmer, Jeffrey K; Klein, Matthew B; Holst, Charles R.
Afiliação
  • Kahn-Kirby AH; BioElectron Technology Corporation, Mountain View, California, United States of America.
  • Amagata A; BioElectron Technology Corporation, Mountain View, California, United States of America.
  • Maeder CI; BioElectron Technology Corporation, Mountain View, California, United States of America.
  • Mei JJ; BioElectron Technology Corporation, Mountain View, California, United States of America.
  • Sideris S; BioElectron Technology Corporation, Mountain View, California, United States of America.
  • Kosaka Y; BioElectron Technology Corporation, Mountain View, California, United States of America.
  • Hinman A; BioElectron Technology Corporation, Mountain View, California, United States of America.
  • Malone SA; BioElectron Technology Corporation, Mountain View, California, United States of America.
  • Bruegger JJ; BioElectron Technology Corporation, Mountain View, California, United States of America.
  • Wang L; BioElectron Technology Corporation, Mountain View, California, United States of America.
  • Kim V; BioElectron Technology Corporation, Mountain View, California, United States of America.
  • Shrader WD; BioElectron Technology Corporation, Mountain View, California, United States of America.
  • Hoff KG; BioElectron Technology Corporation, Mountain View, California, United States of America.
  • Latham JC; BioElectron Technology Corporation, Mountain View, California, United States of America.
  • Ashley EA; Stanford Center for Undiagnosed Diseases, Stanford University School of Medicine, Stanford, California, United States of America.
  • Wheeler MT; Stanford Center for Undiagnosed Diseases, Stanford University School of Medicine, Stanford, California, United States of America.
  • Bertini E; Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children's Research Hospital, Rome, Italy.
  • Carrozzo R; Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children's Research Hospital, Rome, Italy.
  • Martinelli D; Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children's Research Hospital, Rome, Italy.
  • Dionisi-Vici C; Clinical Division and Research Unit of Metabolic Diseases, Bambino Gesù Children's Hospital, Rome, Italy.
  • Chapman KA; Children's National Rare Disease Institute, Children's National Health System, Washington, D.C., United States of America.
  • Enns GM; Department of Pediatrics, Division of Medical Genetics, Stanford University School of Medicine, Stanford, California, United States of America.
  • Gahl W; NIH Undiagnosed Diseases Program, National Human Genome Research Institute (NHGRI), National Institutes of Health, Bethesda, Maryland, United States of America.
  • Wolfe L; NIH Undiagnosed Diseases Program, National Human Genome Research Institute (NHGRI), National Institutes of Health, Bethesda, Maryland, United States of America.
  • Saneto RP; Division of Pediatric Neurology, Department of Neurology, Neuroscience Institute, Seattle Children's Hospital, Seattle, Washington, United States of America.
  • Johnson SC; Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
  • Trimmer JK; Department of Neurology, University of Washington, Seattle, Washington, United States of America.
  • Klein MB; BioElectron Technology Corporation, Mountain View, California, United States of America.
  • Holst CR; BioElectron Technology Corporation, Mountain View, California, United States of America.
PLoS One ; 14(3): e0214250, 2019.
Article em En | MEDLINE | ID: mdl-30921410

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carbolinas / Ubiquinona / Doenças Mitocondriais / Epilepsia / Ferroptose / Fosfolipídeo Hidroperóxido Glutationa Peroxidase Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carbolinas / Ubiquinona / Doenças Mitocondriais / Epilepsia / Ferroptose / Fosfolipídeo Hidroperóxido Glutationa Peroxidase Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos